Press Releases
  


 
  Press Release 01-05-10   CARDIUM TO LAUNCH MEDPODIUM™ PRODUCT LINE INITIALLY COVERING SIX NEW ADVANCED FOOT CARE PRODUCTS FOR PODIATRY PATIENTS TO COMPLEMENT THE EXCELLAGEN PLATFORM

  
  Press Release 12-16-09   CARDIUM REPORTS ON RECENT NORWEGIAN STUDY REVEALING THAT HISTORY OF FOOT ULCERS IS A SIGNIFICANT PREDICTOR OF MORTALITY IN DIABETIC PATIENTS

  
  Press Release 12-14-09   CARDIUM PRESENTS AT TENTH ANNUAL WOUND HEALING: SCIENCE AND INDUSTRY CONFERENCE ON MATRIX WOUND HEALING CLINICAL DEVELOPMENT

  
  Press Release 12-03-09   CARDIUM FILES FDA 510(k) APPLICATION FOR U.S. MARKETING CLEARANCE OF ExcellagenXL™ TOPICAL GEL and ExcellagenFX™ FLOWABLE COLLAGEN PROTEIN-BASED MATRIX FOR DIABETIC, PRESSURE AND VENOUS ULCERS AND OTHER DERMAL WOUNDS

  
  Press Release 11-02-09   CARDIUM ANNOUNCES PLANS TO FILE FDA 510(k) APPLICATION FOR U.S. MARKETING CLEARANCE OF ExcellagenXL™ GEL FOR DIABETIC, PRESSURE AND VENOUS ULCERS AND OTHER TOPICAL WOUNDS

  
  Press Release 10-15-09   POSITIVE FINDINGS FROM EXCELLARATE™ PHASE 1/2 CLINICAL STUDY
PUBLISHED IN JOURNAL OF WOUND REPAIR AND REGENERATION

  
  Press Release 10-14-09   CARDIUM ANNOUNCES COMMERCIAL DEVELOPMENT OF EXCELLAGEN™
A CUSTOMIZED COLLAGEN-BASED TOPICAL GEL FOR INITIAL USE AS AN ADJUNCT TO
SURGICAL DEBRIDEMENT IN PATIENTS WITH DIABETIC FOOT ULCERS

  
  Press Release 10-14-09   CARDIUM REPORTS POSITIVE DATA FROM MATRIX PHASE 2b STUDY OF EXCELLARATE™ TOPICAL GEL FOR NON-HEALING DIABETIC FOOT ULCERS AND PLANS FOR PHASE 3 PROGRAM

  
  Press Release 10-01-09   CARDIUM ANNOUNCES PLANNED RELEASE OF DATA FROM MATRIX EXCELLARATE PHASE 2b CLINICAL STUDY AND ACCEPTANCE OF PHASE 1 / 2 STUDY FOR PUBLICATION IN WOUND REPAIR AND REGENERATION

  
  Press Release 09-14-09   SCIENTIFIC JOURNAL GENE THERAPY REPORTS THAT CARDIUM’S GENE ACTIVATED MATRIX TECHNOLOGY ACCELERATES PERIODONTAL TISSUE REGENERATION

  
  Press Release 08-27-09   CARDIUM REPORTS NON-HEALING WOUNDS CONTINUE TO CHALLENGE PATIENTS AND HEALTHCARE PROVIDERS

  
  Press Release 08-25-09   CARDIUM COMPLETES INITIAL PATIENT EVALUATION PERIOD FOR MATRIX PHASE 2b EXCELLARATE CLINICAL STUDY

  
  Press Release 07-30-09   CARDIUM ANNOUNCES NEW ORTHOBIOLOGICS PRODUCT INITIATIVE EXTENDING GENE ACTIVATED MATRIX TECHNOLOGY

  
  Press Release 07-28-09   CARDIUM PROVIDES UPDATE ON PHASE 2b EXCELLARATE CLINICAL STUDY AND PLANS FOR ADDITIONAL TISSUE REPAIR APPLICATIONS

  
  Press Release 05-28-09   CARDIUM PRESENTS GENE ACTIVATED MATRIX TECHNOLOGY AND UPDATE ON EXCELLARATE CLINICAL DEVELOPMENT PROGRAM AT ASGT ANNUAL MEETING

  
  Press Release 05-12-09   CARDIUM ANNOUNCES CONFERENCE CALL AND WEBCAST TO REVIEW RECENT DEVELOPMENTS AND FUTURE PLANS FOR THE EXCELLARATE™ CLINICAL DEVELOPMENT PROGRAM

 
  Press Release 05-07-09   CARDIUM REPORTS ON NEW EXCELLARATE™ PRODUCT FORMULATIONS TO EXPAND COMMERCIALIZATION POTENTIAL INTO MULTIPLE WOUND HEALING APPLICATIONS

  
  Press Release 05-06-09   CARDIUM ANNOUNCES COMPLETION OF PATIENT RECRUITMENT IN PHASE 2b CLINICAL TRIAL OF EXCELLARATE™ FOR THE POTENTIAL TREATMENT OF DIABETIC FOOT ULCERS

 
  Press Release 11-14-07   CARDIUM INITIATES PHASE 2B EXCELLARATE CLINICAL STUDY FOR DIABETIC ULCERS

  
  Press Release 05-01-07   CARDIUM ADVANCING EXCELLARATE TO PHASE 2B CLINICAL STUDY

  
  Press Release 11-13-06   TREATMENT OF DIABETIC FOOT ULERS TO BE ADDRESSED AT UPCOMING AMERICAN HEART ASSOCIATION MEETING

  
 

Press Release 08-14-06

  

CARDIUM ACQUIRES EXCELLARATE PRODUCT CANDIDATE FOR CHRONIC DIABETIC ULCERS AND RELATED TECHNOLOGY AND ASSETS FROM TISSUE REPAIR COMPANY

  






Home | About TRC | Technology | Product Programs | Preclinical Programs | Investor Information | Contact Us
Site Map | Press Releases | References